EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Editorial

The characteristcs of onti-neutrophyl chtophyl cytophlasmic antibodies in inflamatory bowel disease

Ahmet TEZEL ¹ , Ülkü DAĞLI ¹ , Hülya ÖVER HAMZAOĞLU ¹ , Klara DALVA ² , Çağlar BAYSAL ¹ , Azmi SERİN ¹ , Aysel ÜLKER ³

Author Affiliation(s)

1.

Türkiye yüksek İhtisas Hastanesi Gastroenteroloji Kliniği, Ankara

2.

Ankara Üniversitesi Tıp Fakültesi İç Hastalıkları anabilim Dalı, Hematoloji Kliniği, Ankara

3.

Departments of Gastroenterology and Hematology, Türkiye Yüksek İhtisas Hospital, Ankara

Turk J Gastroenterol 1997; 8: 434-439

Keywords : inflamatory bowel disease, ulcerative colitis, crohn's disease.

Read: 1604 Downloads: 1397 Published: 25 July 2019

Volume 8, Issue 4, December 1997

Previous Article

Files